Antithrombotic treatment after intracerebral haemorrhage

L.A. Perry; E. Berge; J. Bowditch; E. Forfang; O.M. Rønning; Graeme J. Hankey; E. Villanueva; R. Al-Shahi Salman

doi:10.1002/14651858.CD012144

Antithrombotic treatment after intracerebral haemorrhage

L.A. Perry, E. Berge, J. Bowditch, E. Forfang, O.M. Rønning, Graeme J. Hankey, E. Villanueva, R. Al-Shahi Salman

Research output: Contribution to journal › Review article

25 Citations (Scopus)

232 Downloads (Pure)

Abstract

© 2016 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).

Original language	English
Article number	CD012144
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD012144
Publication status	Published - 8 Apr 2016

Access to Document

10.1002/14651858.CD012144

Perry et al., 2016 Antithrombotic treatment after intracerebral haemorrhageFinal published version, 156 KB

Cite this

@article{6e13cae6924c4a168dd1cb3a79e5b99a,

title = "Antithrombotic treatment after intracerebral haemorrhage",

abstract = "{\textcopyright} 2016 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).",

author = "L.A. Perry and E. Berge and J. Bowditch and E. Forfang and O.M. R{\o}nning and Hankey, {Graeme J.} and E. Villanueva and {Al-Shahi Salman}, R.",

year = "2016",

month = apr,

day = "8",

doi = "10.1002/14651858.CD012144",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley & Sons",

number = "4",

}

TY - JOUR

T1 - Antithrombotic treatment after intracerebral haemorrhage

AU - Perry, L.A.

AU - Berge, E.

AU - Bowditch, J.

AU - Forfang, E.

AU - Rønning, O.M.

AU - Hankey, Graeme J.

AU - Villanueva, E.

AU - Al-Shahi Salman, R.

PY - 2016/4/8

Y1 - 2016/4/8

N2 - © 2016 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).

AB - © 2016 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).

U2 - 10.1002/14651858.CD012144

DO - 10.1002/14651858.CD012144

M3 - Review article

SN - 1469-493X

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD012144

ER -

Antithrombotic treatment after intracerebral haemorrhage

Abstract

Access to Document

Fingerprint

Cite this